Transactions under Novozymes’ stock buyback program
Novozymes has now completed the announced share buyback program of B shares worth up to DKK 2 billion in total during 2018.
Please read the full announcement in the attached PDF
Attachment
Upcoming Life Sciences Events
- April 2024
- Pharma-Biotech Product & Company Valuation - An Introductory
- Basel: Swiss Biotech Day 2024
- London: BioTrinity 2024
Latest company news
There are currently no news available for this portal